Dr Reddy’s Laboratories Ltd Net Profit is INR 27.9 crores in Q3 FY 2020-2021

Dr Reddy’s Laboratories Ltd Q3 FY20-21 Quarter Result

Dr Reddy’s Laboratories Ltd Net Profit is INR 27.9 crores in Quarter 3, October – December of Financial Year 2020-2021.

Quarterly Net Earnings Year-on-Year

Dr Reddy’s Laboratories Ltd Quarter Net Profit is -105 % from Last Year Quarter Net Loss and Net Profit of INR 27.9 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Loss was INR -538.4 crores.

Quarterly Net Sales Year-on-Year

Dr Reddy’s Laboratories Ltd Quarter Sale is up 12 % from Last Quarter. Sales of 4941.9 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 4397.1

Annual Sales & Net Earning

Dr Reddy’s Laboratories Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 15448.2 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 1950.0 crores.


Dr Reddy’s Laboratories Ltd Stock Information

SectorPharmaceuticals
IndustryPharmaceuticals – Indian – Bulk Drugs & Formln
AboutDr Reddys Laboratories is a leading India-based pharmaceutical company headquartered and having its registered offi ce in Hyderabad, Telangana, India. Through its three businesses – Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products the Company off ers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and diff erentiated formulations.(
Latest Qaurter EPS1.6777078192101524

Dr Reddy’s Laboratories Ltd Stock Analysis:

Get more Quarterly Earnings Results of companies

Get complete data on Dr Reddy’s Laboratories Ltd

Leave a Comment

Your email address will not be published. Required fields are marked *